Cysmethynil

Overview

Cysmethynil is an Icmt inhibitor( IC 50 = 2.4 μM). Cysmethynil inhibites RAS membrane binding and EGF signal transduction. Cysmethynil prevents the cells in the G1 phase and induces autophagy . Cysmethynil inhibits PC3 cells proliferation, has synergistic effect with Paclitaxel ( HY-B0015 ) and Doxorubicin ( HY-15142A ). Cysmethynil has anti-tumor effects and can be used for solid tumor (such as prostate cancer et al.) research.

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > ICMT

Product Information

• Catalog No.: HY-16160
• CAS No.: 851636-83-4
• Molecular Formula: C25H32N2O
• Molecular Weight: 376.53
• Purity: 99.07%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source